MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet; S. Arnavielhe; A. Bedbrook; M. Bewick; D. Laune; E. Mathieu-dupas; R. Murray; G. L. Onorato; J. L. Pépin; R. Picard; F. Portejoie; E. Costa; J. Fonseca; O. Lourenço; M. Morais-Almeida; A. Todo-bom; A. A. Cruz; J. da Silva; F. S. Serpa; M. Illario; E. Menditto; L. Cecchi; R. Monti; L. Napoli; M. T. Ventura; G. De Feo; M. Fuentes Perez; Y. R. Huerta Villabolos; D. Rivero-yeverino; E. Rodriguez-zagal; F. Amat; I. Annesi-maesano; I. Bosse; P. Demoly; P. Devillier; J. F. Fontaine; J. Just; T. P. Kuna; B. Samolinski; A. Valiulis; R. Emuzyte; V. Kvedariene; D. Ryan; A. Sheikh; P. Schmidt-grendelmeier; L. Klimek; O. Pfaar; K. C. Bergmann; R. Mösges; T. Zuberbier; R. E. Roller-wirnsberger; P. Tomazic; W. J. Fokkens; N. H. Chavannes; S. Reitsma; J. M. Anto; V. Cardona; T. Dedeu; J. Mullol; T. Haahtela; J. Salimäki; S. Toppila-Salmi; E. Valovirta; B. Gemicioğlu; A. Yorgancioglu; N. Papadopoulos; E. P. Prokopakis; R. O’hehir; J. C. Ivancevich; H. Neffen; E. Zernotti; I. Kull; E. Melén; M. Wickman; C. Bachert; P. Hellings; S. Palkonen; C. Bindslev-jensen; E. Eller; S. Waserman; M. Sova; G. De Vries; M. van Eerd; I. Agache; T. Casale; M. Dykewickz; R. N. Naclerio; Y. Okamoto; D. V. Wallace; the MASK Study Group

doi:10.1186/s13601-018-0227-6

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-dupas, R. Murray, G. L. Onorato, J. L. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-bom, A. A. Cruz, J. da Silva, F. S. Serpa, M. IllarioE. Menditto, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, M. Fuentes Perez, Y. R. Huerta Villabolos, D. Rivero-yeverino, E. Rodriguez-zagal, F. Amat, I. Annesi-maesano, I. Bosse, P. Demoly, P. Devillier, J. F. Fontaine, J. Just, T. P. Kuna, B. Samolinski, A. Valiulis, R. Emuzyte, V. Kvedariene, D. Ryan, A. Sheikh, P. Schmidt-grendelmeier, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-wirnsberger, P. Tomazic, W. J. Fokkens, N. H. Chavannes, S. Reitsma, J. M. Anto, V. Cardona, T. Dedeu, J. Mullol, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, B. Gemicioğlu, A. Yorgancioglu, N. Papadopoulos, E. P. Prokopakis, R. O’hehir, J. C. Ivancevich, H. Neffen, E. Zernotti, I. Kull, E. Melén, M. Wickman, C. Bachert, P. Hellings, S. Palkonen, C. Bindslev-jensen, E. Eller, S. Waserman, M. Sova, G. De Vries, M. van Eerd, I. Agache, T. Casale, M. Dykewickz, R. N. Naclerio, Y. Okamoto, D. V. Wallace, the MASK Study Group

Medicine Alfred Hospital

Research output: Contribution to journal › Review Article › Research › peer-review

113 Citations (Scopus)

Abstract

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

Original language	English
Article number	45
Number of pages	21
Journal	Clinical and Translational Allergy
Volume	8
Issue number	1
DOIs	https://doi.org/10.1186/s13601-018-0227-6
Publication status	Published - 25 Oct 2018

Keywords

App
ARIA
Asthma
Care pathways
MASK
mHealth
Rhinitis

Access to Document

10.1186/s13601-018-0227-6

271935369-oaFinal published version, 2.49 MB

Cite this

Bousquet, J., Arnavielhe, S., Bedbrook, A., Bewick, M., Laune, D., Mathieu-dupas, E., Murray, R., Onorato, G. L., Pépin, J. L., Picard, R., Portejoie, F., Costa, E., Fonseca, J., Lourenço, O., Morais-Almeida, M., Todo-bom, A., Cruz, A. A., Silva, J. D., Serpa, F. S., ... the MASK Study Group (2018). MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy, 8(1), Article 45. https://doi.org/10.1186/s13601-018-0227-6

@article{0a4ba58011e947f0b9c71aa510082326,

title = "MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence",

abstract = "mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.",

keywords = "App, ARIA, Asthma, Care pathways, MASK, mHealth, Rhinitis",

author = "J. Bousquet and S. Arnavielhe and A. Bedbrook and M. Bewick and D. Laune and E. Mathieu-dupas and R. Murray and Onorato, {G. L.} and P{\'e}pin, {J. L.} and R. Picard and F. Portejoie and E. Costa and J. Fonseca and O. Louren{\c c}o and M. Morais-Almeida and A. Todo-bom and Cruz, {A. A.} and Silva, {J. da} and Serpa, {F. S.} and M. Illario and E. Menditto and L. Cecchi and R. Monti and L. Napoli and Ventura, {M. T.} and {De Feo}, G. and D. Larenas-linnemann and {Fuentes Perez}, M. and {Huerta Villabolos}, {Y. R.} and D. Rivero-yeverino and E. Rodriguez-zagal and F. Amat and I. Annesi-maesano and I. Bosse and P. Demoly and P. Devillier and Fontaine, {J. F.} and J. Just and Kuna, {T. P.} and B. Samolinski and A. Valiulis and R. Emuzyte and V. Kvedariene and D. Ryan and A. Sheikh and P. Schmidt-grendelmeier and L. Klimek and O. Pfaar and Bergmann, {K. C.} and R. M{\"o}sges and T. Zuberbier and Roller-wirnsberger, {R. E.} and P. Tomazic and Fokkens, {W. J.} and Chavannes, {N. H.} and S. Reitsma and Anto, {J. M.} and V. Cardona and T. Dedeu and J. Mullol and T. Haahtela and J. Salim{\"a}ki and S. Toppila-Salmi and E. Valovirta and B. Gemicioğlu and A. Yorgancioglu and N. Papadopoulos and Prokopakis, {E. P.} and S. Bosnic-anticevich and R. O{\textquoteright}hehir and Ivancevich, {J. C.} and H. Neffen and E. Zernotti and I. Kull and E. Mel{\'e}n and M. Wickman and C. Bachert and P. Hellings and S. Palkonen and C. Bindslev-jensen and E. Eller and S. Waserman and M. Sova and {De Vries}, G. and {van Eerd}, M. and I. Agache and T. Casale and M. Dykewickz and Naclerio, {R. N.} and Y. Okamoto and Wallace, {D. V.} and Hellings, {P. W.} and W. Aberer and Akdis, {C. A.} and M. Akdis and Alberti, {M. R.} and R. Almeida and R. Angles and Ansotegui, {I. J.} and S. Arnavielle and E. Asayag and A. Asarnoj and H. Arshad and F. Avolio and E. Bacci and I. Baiardini and C. Barbara and M. Barbagallo and I. Baroni and Barreto, {B. A.} and X. Basagana and Bateman, {E. D.} and M. Bedolla-Barajas and B. Begh{\'e} and Bel, {E. H.} and Bennoor, {K. S.} and M. Benson and L. Bertorello and Bia{\l}oszewski, {A. Z.} and T. Bieber and S. Bialek and L. Bjermer and H. Blain and F. Blasi and A. Blua and {Bochenska Marciniak}, M. and I. Bogus-Buczynska and Boner, {A. L.} and M. Bonini and S. Bonini and Bosnic-Anticevich, {C. S.} and J. Bouchard and Boulet, {L. P.} and R. Bourret and Bousquet, {P. J.} and F. Braido and V. Briedis and Brightling, {C. E.} and J. Brozek and C. Bucca and R. Buhl and R. Buonaiuto and C. Panaitescu and {Burguete Caba{\~n}as}, {M. T.} and E. Burte and A. Bush and F. Caballero-Fonseca and D. Caillot and D. Caimmi and Calderon, {M. A.} and Camargos, {P. A.M.} and T. Camuzat and G. Canfora and Canonica, {G. W.} and Carlsen, {K. H.} and P. Carreiro-Martins and Carriazo, {A. M.} and W. Carr and C. Cartier and G. Castellano and Cepeda, {A. M.} and Y. Chen and R. Chiron and T. Chivato and E. Chkhartishvili and Chuchalin, {A. G.} and Chung, {K. F.} and Ciaravolo, {M. M.} and A. Ciceran and C. Cingi and G. Ciprandi and {Carvalho Coehlo}, {A. C.} and L. Colas and E. Colgan and J. Coll and D. Conforti and {Correia de Sousa}, J. and Cort{\'e}s-Grimaldo, {R. M.} and F. Corti and Costa-Dominguez, {M. C.} and Courbis, {A. L.} and L. Cox and M. Crescenzo and A. Custovic and W. Czarlewski and Dahlen, {S. E.} and C. Dario and {da Silva}, J. and Y. Dauvilliers and U. Darsow and {De Blay}, F. and {De Carlo}, G. and {de F{\'a}tima Emerson}, M. and {De Martino}, B. and {de Paula Motta Rubini}, N. and D. Deleanu and Denburg, {J. A.} and {Di Capua Ercolano}, S. and {Di Carluccio}, N. and A. Didier and D. Dokic and Dominguez-Silva, {M. G.} and H. Douagui and G. Dray and R. Dubakiene and Durham, {S. R.} and {Du Toit}, G. and Dykewicz, {M. S.} and Y. El-Gamal and P. Eklund and J. Farrell and A. Farsi and {Ferreira de Mello}, J. and J. Ferrero and A. Fink-Wagner and A. Fiocchi and Fonseca, {J. A.} and S. Forti and Fuentes-Perez, {J. M.} and G{\'a}lvez-Romero, {J. L.} and A. Gamkrelidze and J. Garcia-Aymerich and Garc{\'i}a-Cobas, {C. Y.} and Garcia-Cruz, {M. H.} and S. Genova and C. George and Gereda, {J. E.} and {Gerth van Wijk}, R. and Gomez, {R. M.} and J. G{\'o}mez-Vera and {Gonz{\'a}lez Diaz}, S. and M. Gotua and I. Grisle and M. Guidacci and Guldemond, {N. A.} and Z. Gutter and Guzm{\'a}n, {M. A.} and J. Hajjam and L. Hern{\'a}ndez and Hourihane, {J. O.{\textquoteright}.B.} and Huerta-Villalobos, {Y. R.} and M. Humbert and G. Iaccarino and Jares, {E. J.} and E. Jassem and Johnston, {S. L.} and G. Joos and Jung, {K. S.} and M. Jutel and I. Kaidashev and {the MASK Study Group}",

year = "2018",

month = oct,

day = "25",

doi = "10.1186/s13601-018-0227-6",

language = "English",

volume = "8",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "BioMed Central",

number = "1",

}

Bousquet, J, Arnavielhe, S, Bedbrook, A, Bewick, M, Laune, D, Mathieu-dupas, E, Murray, R, Onorato, GL, Pépin, JL, Picard, R, Portejoie, F, Costa, E, Fonseca, J, Lourenço, O, Morais-Almeida, M, Todo-bom, A, Cruz, AA, Silva, JD, Serpa, FS, Illario, M, Menditto, E, Cecchi, L, Monti, R, Napoli, L, Ventura, MT, De Feo, G, Fuentes Perez, M, Huerta Villabolos, YR, Rivero-yeverino, D, Rodriguez-zagal, E, Amat, F, Annesi-maesano, I, Bosse, I, Demoly, P, Devillier, P, Fontaine, JF, Just, J, Kuna, TP, Samolinski, B, Valiulis, A, Emuzyte, R, Kvedariene, V, Ryan, D, Sheikh, A, Schmidt-grendelmeier, P, Klimek, L, Pfaar, O, Bergmann, KC, Mösges, R, Zuberbier, T, Roller-wirnsberger, RE, Tomazic, P, Fokkens, WJ, Chavannes, NH, Reitsma, S, Anto, JM, Cardona, V, Dedeu, T, Mullol, J, Haahtela, T, Salimäki, J, Toppila-Salmi, S, Valovirta, E, Gemicioğlu, B, Yorgancioglu, A, Papadopoulos, N, Prokopakis, EP, O’hehir, R, Ivancevich, JC, Neffen, H, Zernotti, E, Kull, I, Melén, E, Wickman, M, Bachert, C, Hellings, P, Palkonen, S, Bindslev-jensen, C, Eller, E, Waserman, S, Sova, M, De Vries, G, van Eerd, M, Agache, I, Casale, T, Dykewickz, M, Naclerio, RN, Okamoto, Y, Wallace, DV & the MASK Study Group 2018, 'MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence', Clinical and Translational Allergy, vol. 8, no. 1, 45. https://doi.org/10.1186/s13601-018-0227-6

TY - JOUR

T1 - MASK 2017

T2 - ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

AU - Bousquet, J.

AU - Arnavielhe, S.

AU - Bedbrook, A.

AU - Bewick, M.

AU - Laune, D.

AU - Mathieu-dupas, E.

AU - Murray, R.

AU - Onorato, G. L.

AU - Pépin, J. L.

AU - Picard, R.

AU - Portejoie, F.

AU - Costa, E.

AU - Fonseca, J.

AU - Lourenço, O.

AU - Morais-Almeida, M.

AU - Todo-bom, A.

AU - Cruz, A. A.

AU - Silva, J. da

AU - Serpa, F. S.

AU - Illario, M.

AU - Menditto, E.

AU - Cecchi, L.

AU - Monti, R.

AU - Napoli, L.

AU - Ventura, M. T.

AU - De Feo, G.

AU - Larenas-linnemann, D.

AU - Fuentes Perez, M.

AU - Huerta Villabolos, Y. R.

AU - Rivero-yeverino, D.

AU - Rodriguez-zagal, E.

AU - Amat, F.

AU - Annesi-maesano, I.

AU - Bosse, I.

AU - Demoly, P.

AU - Devillier, P.

AU - Fontaine, J. F.

AU - Just, J.

AU - Kuna, T. P.

AU - Samolinski, B.

AU - Valiulis, A.

AU - Emuzyte, R.

AU - Kvedariene, V.

AU - Ryan, D.

AU - Sheikh, A.

AU - Schmidt-grendelmeier, P.

AU - Klimek, L.

AU - Pfaar, O.

AU - Bergmann, K. C.

AU - Mösges, R.

AU - Zuberbier, T.

AU - Roller-wirnsberger, R. E.

AU - Tomazic, P.

AU - Fokkens, W. J.

AU - Chavannes, N. H.

AU - Reitsma, S.

AU - Anto, J. M.

AU - Cardona, V.

AU - Dedeu, T.

AU - Mullol, J.

AU - Haahtela, T.

AU - Salimäki, J.

AU - Toppila-Salmi, S.

AU - Valovirta, E.

AU - Gemicioğlu, B.

AU - Yorgancioglu, A.

AU - Papadopoulos, N.

AU - Prokopakis, E. P.

AU - Bosnic-anticevich, S.

AU - O’hehir, R.

AU - Ivancevich, J. C.

AU - Neffen, H.

AU - Zernotti, E.

AU - Kull, I.

AU - Melén, E.

AU - Wickman, M.

AU - Bachert, C.

AU - Hellings, P.

AU - Palkonen, S.

AU - Bindslev-jensen, C.

AU - Eller, E.

AU - Waserman, S.

AU - Sova, M.

AU - De Vries, G.

AU - van Eerd, M.

AU - Agache, I.

AU - Casale, T.

AU - Dykewickz, M.

AU - Naclerio, R. N.

AU - Okamoto, Y.

AU - Wallace, D. V.

AU - Hellings, P. W.

AU - Aberer, W.

AU - Akdis, C. A.

AU - Akdis, M.

AU - Alberti, M. R.

AU - Almeida, R.

AU - Angles, R.

AU - Ansotegui, I. J.

AU - Arnavielle, S.

AU - Asayag, E.

AU - Asarnoj, A.

AU - Arshad, H.

AU - Avolio, F.

AU - Bacci, E.

AU - Baiardini, I.

AU - Barbara, C.

AU - Barbagallo, M.

AU - Baroni, I.

AU - Barreto, B. A.

AU - Basagana, X.

AU - Bateman, E. D.

AU - Bedolla-Barajas, M.

AU - Beghé, B.

AU - Bel, E. H.

AU - Bennoor, K. S.

AU - Benson, M.

AU - Bertorello, L.

AU - Białoszewski, A. Z.

AU - Bieber, T.

AU - Bialek, S.

AU - Bjermer, L.

AU - Blain, H.

AU - Blasi, F.

AU - Blua, A.

AU - Bochenska Marciniak, M.

AU - Bogus-Buczynska, I.

AU - Boner, A. L.

AU - Bonini, M.

AU - Bonini, S.

AU - Bosnic-Anticevich, C. S.

AU - Bouchard, J.

AU - Boulet, L. P.

AU - Bourret, R.

AU - Bousquet, P. J.

AU - Braido, F.

AU - Briedis, V.

AU - Brightling, C. E.

AU - Brozek, J.

AU - Bucca, C.

AU - Buhl, R.

AU - Buonaiuto, R.

AU - Panaitescu, C.

AU - Burguete Cabañas, M. T.

AU - Burte, E.

AU - Bush, A.

AU - Caballero-Fonseca, F.

AU - Caillot, D.

AU - Caimmi, D.

AU - Calderon, M. A.

AU - Camargos, P. A.M.

AU - Camuzat, T.

AU - Canfora, G.

AU - Canonica, G. W.

AU - Carlsen, K. H.

AU - Carreiro-Martins, P.

AU - Carriazo, A. M.

AU - Carr, W.

AU - Cartier, C.

AU - Castellano, G.

AU - Cepeda, A. M.

AU - Chen, Y.

AU - Chiron, R.

AU - Chivato, T.

AU - Chkhartishvili, E.

AU - Chuchalin, A. G.

AU - Chung, K. F.

AU - Ciaravolo, M. M.

AU - Ciceran, A.

AU - Cingi, C.

AU - Ciprandi, G.

AU - Carvalho Coehlo, A. C.

AU - Colas, L.

AU - Colgan, E.

AU - Coll, J.

AU - Conforti, D.

AU - Correia de Sousa, J.

AU - Cortés-Grimaldo, R. M.

AU - Corti, F.

AU - Costa-Dominguez, M. C.

AU - Courbis, A. L.

AU - Cox, L.

AU - Crescenzo, M.

AU - Custovic, A.

AU - Czarlewski, W.

AU - Dahlen, S. E.

AU - Dario, C.

AU - da Silva, J.

AU - Dauvilliers, Y.

AU - Darsow, U.

AU - De Blay, F.

AU - De Carlo, G.

AU - de Fátima Emerson, M.

AU - De Martino, B.

AU - de Paula Motta Rubini, N.

AU - Deleanu, D.

AU - Denburg, J. A.

AU - Di Capua Ercolano, S.

AU - Di Carluccio, N.

AU - Didier, A.

AU - Dokic, D.

AU - Dominguez-Silva, M. G.

AU - Douagui, H.

AU - Dray, G.

AU - Dubakiene, R.

AU - Durham, S. R.

AU - Du Toit, G.

AU - Dykewicz, M. S.

AU - El-Gamal, Y.

AU - Eklund, P.

AU - Farrell, J.

AU - Farsi, A.

AU - Ferreira de Mello, J.

AU - Ferrero, J.

AU - Fink-Wagner, A.

AU - Fiocchi, A.

AU - Fonseca, J. A.

AU - Forti, S.

AU - Fuentes-Perez, J. M.

AU - Gálvez-Romero, J. L.

AU - Gamkrelidze, A.

AU - Garcia-Aymerich, J.

AU - García-Cobas, C. Y.

AU - Garcia-Cruz, M. H.

AU - Genova, S.

AU - George, C.

AU - Gereda, J. E.

AU - Gerth van Wijk, R.

AU - Gomez, R. M.

AU - Gómez-Vera, J.

AU - González Diaz, S.

AU - Gotua, M.

AU - Grisle, I.

AU - Guidacci, M.

AU - Guldemond, N. A.

AU - Gutter, Z.

AU - Guzmán, M. A.

AU - Hajjam, J.

AU - Hernández, L.

AU - Hourihane, J. O.’.B.

AU - Huerta-Villalobos, Y. R.

AU - Humbert, M.

AU - Iaccarino, G.

AU - Jares, E. J.

AU - Jassem, E.

AU - Johnston, S. L.

AU - Joos, G.

AU - Jung, K. S.

AU - Jutel, M.

AU - Kaidashev, I.

AU - the MASK Study Group

PY - 2018/10/25

Y1 - 2018/10/25

N2 - mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

AB - mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

KW - App

KW - ARIA

KW - Asthma

KW - Care pathways

KW - MASK

KW - mHealth

KW - Rhinitis

UR - http://www.scopus.com/inward/record.url?scp=85055564214&partnerID=8YFLogxK

U2 - 10.1186/s13601-018-0227-6

DO - 10.1186/s13601-018-0227-6

M3 - Review Article

AN - SCOPUS:85055564214

SN - 2045-7022

VL - 8

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

IS - 1

M1 - 45

ER -

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Abstract

Keywords

Access to Document

Other files and links

Cite this